Etsuko Usuki

588 total citations
14 papers, 429 citations indexed

About

Etsuko Usuki is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Pharmacology. According to data from OpenAlex, Etsuko Usuki has authored 14 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 6 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Etsuko Usuki's work include Pharmacological Effects and Toxicity Studies (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Etsuko Usuki is often cited by papers focused on Pharmacological Effects and Toxicity Studies (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Etsuko Usuki collaborates with scholars based in United States, Australia and South Africa. Etsuko Usuki's co-authors include Neal Castagnoli, Neal Castagnoli, Andrew Parkinson, Hans Rollema, Cornelis J. Van der Schyf, Robin E. Pearce, Miyoshi Fukui, Kazuei Igarashi, Fumiyo Kasuya and Kay Castagnoli and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Life Sciences and Journal of Pharmaceutical Sciences.

In The Last Decade

Etsuko Usuki

14 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Etsuko Usuki United States 10 159 115 102 98 96 14 429
J. Cobaleda Spain 14 376 2.4× 100 0.9× 64 0.6× 111 1.1× 80 0.8× 20 615
Monique Schmitt Switzerland 11 113 0.7× 109 0.9× 59 0.6× 117 1.2× 61 0.6× 23 607
David J. Sequeira United States 12 135 0.8× 59 0.5× 83 0.8× 121 1.2× 103 1.1× 19 366
Birgit A. P. M. Vogels Netherlands 9 166 1.0× 50 0.4× 61 0.6× 97 1.0× 37 0.4× 11 474
Kristian T. Hansen Denmark 12 224 1.4× 256 2.2× 200 2.0× 43 0.4× 57 0.6× 18 666
J. Roba Belgium 12 62 0.4× 125 1.1× 101 1.0× 92 0.9× 94 1.0× 44 442
Dafang Wu United States 8 211 1.3× 143 1.2× 97 1.0× 68 0.7× 54 0.6× 8 621
A. von Hodenberg Germany 10 69 0.4× 193 1.7× 98 1.0× 141 1.4× 138 1.4× 17 636
Caiping Yao United States 11 133 0.8× 95 0.8× 57 0.6× 92 0.9× 92 1.0× 17 329
Tsun Chang United States 11 52 0.3× 120 1.0× 74 0.7× 62 0.6× 90 0.9× 22 472

Countries citing papers authored by Etsuko Usuki

Since Specialization
Citations

This map shows the geographic impact of Etsuko Usuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etsuko Usuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etsuko Usuki more than expected).

Fields of papers citing papers by Etsuko Usuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etsuko Usuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etsuko Usuki. The network helps show where Etsuko Usuki may publish in the future.

Co-authorship network of co-authors of Etsuko Usuki

This figure shows the co-authorship network connecting the top 25 collaborators of Etsuko Usuki. A scholar is included among the top collaborators of Etsuko Usuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etsuko Usuki. Etsuko Usuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Eichenbaum, Gary, Andrew Parkinson, Mark D. Johnson, et al.. (2011). Use of Enzyme Inhibitors to Evaluate the Conversion Pathways of Ester and Amide Prodrugs: A Case Study Example with the Prodrug Ceftobiprole Medocaril. Journal of Pharmaceutical Sciences. 101(3). 1242–1252. 6 indexed citations
2.
Nassar, Alaa-Eldin F., Ivan King, Brandy L. Paris, et al.. (2009). An in Vitro Evaluation of the Victim and Perpetrator Potential of the Anticancer Agent Laromustine (VNP40101M), Based on Reaction Phenotyping and Inhibition and Induction of Cytochrome P450 Enzymes. Drug Metabolism and Disposition. 37(9). 1922–1930. 14 indexed citations
3.
Leone, Angelique M., Michael McMillian, Alex Nie, et al.. (2007). Evaluation of Felbamate and Other Antiepileptic Drug Toxicity Potential Based on Hepatic Protein Covalent Binding and Gene Expression. Chemical Research in Toxicology. 20(4). 600–608. 35 indexed citations
4.
Wang, Michael Zhuo, Etsuko Usuki, Michael Hall, et al.. (2006). CYP4F Enzymes Are the Major Enzymes in Human Liver Microsomes That Catalyze the O-Demethylation of the Antiparasitic Prodrug DB289 [2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime]. Drug Metabolism and Disposition. 34(12). 1985–1994. 73 indexed citations
5.
Usuki, Etsuko, et al.. (2002). Metabolic studies on haloperidol and its tetrahydropyridinyl dehydration product (HPTP) in C57BL/6 mouse brain preparations. Neurotoxicity Research. 4(1). 51–58. 8 indexed citations
6.
Castagnoli, Neal, Kay Castagnoli, Etsuko Usuki, et al.. (1999). Enzyme-catalyzed bioactivation of cyclic tertiary amines to form potential neurotoxins.. PubMed. 51(1). 31–8. 3 indexed citations
7.
Usuki, Etsuko, Cornelis J. Van der Schyf, & Neal Castagnoli. (1998). Metabolism of Haloperidol and Its Tetrahydropyridine Dehydration Product HPTP. Drug Metabolism Reviews. 30(4). 809–826. 15 indexed citations
8.
Riker, Richard R., et al.. (1997). Metabolism of haloperidol to pyridinium species in patients receiving high doses intravenously: Is HPTP an intermediate?. Life Sciences. 61(24). 2383–2390. 20 indexed citations
9.
Usuki, Etsuko, et al.. (1996). Haloperidol and its tetrahydropyridine derivative (HPTP) are metabolized to potentially neurotoxic pyridinium species in the baboon. Life Sciences. 59(17). 1473–1482. 21 indexed citations
10.
Usuki, Etsuko, Robin E. Pearce, Andrew Parkinson, & Neal Castagnoli. (1996). Studies on the Conversion of Haloperidol and Its Tetrahydropyridine Dehydration Product to Potentially Neurotoxic Pyridinium Metabolites by Human Liver Microsomes. Chemical Research in Toxicology. 9(4). 800–806. 50 indexed citations
11.
Igarashi, Kazuei, Fumiyo Kasuya, Miyoshi Fukui, Etsuko Usuki, & Neal Castagnoli. (1995). Studies on the metabolism of haloperidol (HP): The role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP. Life Sciences. 57(26). 2439–2446. 52 indexed citations
12.
Rollema, Hans, et al.. (1994). MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.. Journal of Pharmacology and Experimental Therapeutics. 268(1). 380–387. 105 indexed citations
13.
Schyf, Cornelis J. Van der, Kay Castagnoli, Etsuko Usuki, et al.. (1994). Metabolic Studies on Haloperidol and Its Tetrahydropyridine Analog in C57BL/6 Mice. Chemical Research in Toxicology. 7(3). 281–285. 24 indexed citations
14.
Oizumi, Takaaki, et al.. (1983). Digestibility of actomyosin of Antarctic krill Euphausia superba by its digestive protease. Bulletin of the Japanese Society of Scientific Fisheries. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Cobaleda Breakdown of academic impact, for papers by Monique Schmitt Breakdown of academic impact, for papers by David J. Sequeira Breakdown of academic impact, for papers by Birgit A. P. M. Vogels Breakdown of academic impact, for papers by Kristian T. Hansen Breakdown of academic impact, for papers by J. Roba Breakdown of academic impact, for papers by Dafang Wu Breakdown of academic impact, for papers by A. von Hodenberg Breakdown of academic impact, for papers by Caiping Yao Breakdown of academic impact, for papers by Tsun Chang
Rankless by CCL
2026